Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

Share Price is delayed by 15 minutes
Get Live Data
25.00    0.00 (0.00%)
Bid:
24.00
Ask:
26.00
Spread: 2.00 (8.333%)
Market Cap: £27.00m
CKT Live PriceLast checked at - London Stock Exchange

Intraday Checkit Share Chart

Trading Update

13 Feb 2020 07:00

RNS Number : 8310C
Checkit PLC
13 February 2020
 

Checkit plc

(the "Group")

Trading Update

 

Checkit plc is pleased to provide a trading update for its financial year ending 31 January 2020 ("FY20"). The Group's performance for the full year was in line with management expectations.

A summary of its unaudited sales and cash is as follows:

 

£'m

FY2019 actual

FY2019 normalised*

FY2020

actual

FY2020 normalised*

%

change actual

%

change

normalised*

Sales

 

 

 

 

 

 

Checkit Europe

1.0

1.0

1.3

1.3

30%

30%

Checkit UK

-

10.8

8.5

11.6

-

7%

Checkit total

1.0

11.8

9.8

12.8

870%

8%

EET

2.6

2.6

2.0

2.0

-23%

-23%

Total sales

3.6

14.4

11.8

14.8

228%

3%

 

 

 

 

 

 

 

Cash

10.1

-

14.3

-

42.5%

-

 

*Normalised sales illustrate sales that would have been included in the Group's financial results had Checkit UK Limited ("CUK"), which was acquired on 14 May 2019, been owned by the Group throughout both periods.

 

Checkit sales were above market expectations, particularly in the area of Checkit UK's installation work, which historically has operated at low margins. Checkit Europe and Checkit UK are in the process of being merged. Consequently, the board does not intend to report separately for future accounting periods.

The board continues to be excited by the medium-term prospects of the Checkit businesses. Several opportunities to improve profitability have been identified and are being implemented in the merged businesses.

Elektron Eye Technology ("EET") experienced a slowdown in sales in the second half of FY20. As previously announced, the board continues to seek a buyer for this non-core business. In view of the limited interest received to date, the board has reduced its expectations regarding potential disposal proceeds.

The cash balance at 31 January 2020 was higher than expected due to repayment of amounts owed (£2.6m) by the Elektron Technology 2012 Employment Benefit Trust following its participation in the recent tender offer. This was partially offset by a working capital adjustment resulting in a return of cash (£0.8m) to the acquirers of the Bulgin business.

The board is currently reviewing its amortisation policy in respect of acquired intangibles and capitalised development costs (in consultation with its auditors) with a view to shortening amortisation periods. This work will be completed by the time of the preliminary announcement scheduled for 14 May 2020.

Keith Daley, Executive Chair said: "This was a good performance during a period of major corporate change as a result of the disposal of the Bulgin business. We are pleased with the performance of Checkit UK, our recent acquisition, and the integration plan we have put in place is on track. The opportunities for the combined group remain attractive and we are optimistic about future growth."

 

 

Checkit plc

+44 (0) 1223 371 000

www.checkit.net

Keith Daley (Executive Chairman)

Andrew Weatherstone (Chief Financial Officer and Company Secretary)

N+1 Singer (Nominated Adviser and Broker)

+44 (0)207 496 3000

Shaun Dobson / George Tzimas (Corporate Finance)

Rachel Hayes (Corporate Broking)

Yellowstone Advisory (Investor Relations)

Alex Schlich

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTDLLFFBLLEBBK
Date   Source Headline
29th Mar 20187:00 amRNSBulgin announces agreement with Arrow Electronics
6th Mar 20187:00 amRNSFSA successfully completes trials with Checkit
27th Feb 20187:00 amRNSHolding(s) in Company
16th Feb 20187:00 amRNSDisposal of Queensgate Nano
8th Feb 20187:00 amRNSTrading Statement
26th Jan 20183:37 pmRNSHolding(s) in Company
25th Jan 20185:58 pmRNSHolding(s) in Company
25th Jan 20187:00 amRNSAcquisition of IP in EET business
19th Jan 20183:45 pmRNSHolding(s) in Company
2nd Jan 20187:00 amRNSChange of Nominated Adviser and Broker
12th Dec 20177:00 amRNSGrant of Options
6th Dec 20174:02 pmRNSHolding(s) in Company
2nd Nov 20177:00 amRNSTrading Statement
23rd Oct 20174:16 pmRNSDirector/PDMR Shareholding
20th Oct 20177:00 amRNSDisposal of Sheen Instruments
16th Oct 201712:25 pmRNSHolding(s) in Company
27th Sep 20174:20 pmRNSHolding(s) in Company
21st Sep 20177:00 amRNSHalf-year Report
19th Sep 20177:00 amRNSContract Win
10th Aug 20177:00 amRNSTrading Update and Notification of Interim Results
31st Jul 20177:00 amRNSDisposal
13th Jul 201710:01 amRNSHolding(s) in Company
6th Jul 20173:00 pmRNSResult of AGM
6th Jul 20177:00 amRNSAGM Statement
16th Jun 201710:40 amRNSHolding(s) in Company
13th Jun 20177:57 amRNSHolding(s) in Company
6th Jun 201711:26 amRNSAnnual Report and Notice of AGM
18th May 20177:00 amRNSFinal Results
2nd May 20177:00 amRNSNotice of Results & AGM
27th Mar 20177:00 amRNSDisposal
8th Feb 20177:00 amRNSTrading Update
19th Jan 20177:00 amRNSDirector/PDMR Shareholding
14th Dec 20164:54 pmRNSHolding(s) in Company
13th Dec 20167:00 amRNSDirector/PDMR Shareholding
8th Dec 20169:00 amRNSReview of Operations
2nd Dec 20167:00 amRNSDisposal
30th Sep 20162:43 pmRNSDisposal of Carnation Designs
22nd Sep 20167:00 amRNSHalf-year Report
30th Aug 20169:52 amRNSHolding(s) in Company
1st Aug 20167:00 amRNSDirector/PDMR Shareholding
28th Jul 20163:56 pmRNSResult of AGM
28th Jul 20167:00 amRNSTrading Update
4th Jul 201610:40 amRNSLapsing of Options
30th Jun 20167:00 amRNSAnnual Report and Notice of AGM
9th Jun 20167:00 amRNSFinal Results
23rd May 20167:00 amRNSDisposal of Agar Scientific
18th May 20169:56 amRNSHolding(s) in Company
13th May 201610:06 amRNSHolding(s) in Company
20th Apr 20162:54 pmRNSDerivative Claim - Update
22nd Feb 20167:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.